AU7526894A - B7-2: ctla4/cd28 counter receptor - Google Patents

B7-2: ctla4/cd28 counter receptor

Info

Publication number
AU7526894A
AU7526894A AU75268/94A AU7526894A AU7526894A AU 7526894 A AU7526894 A AU 7526894A AU 75268/94 A AU75268/94 A AU 75268/94A AU 7526894 A AU7526894 A AU 7526894A AU 7526894 A AU7526894 A AU 7526894A
Authority
AU
Australia
Prior art keywords
ctla4
counter receptor
receptor
counter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75268/94A
Inventor
Jeffrey A Bluestone
Deborah J Lenschow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arch Development Corp
Original Assignee
Arch Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arch Development Corp filed Critical Arch Development Corp
Publication of AU7526894A publication Critical patent/AU7526894A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU75268/94A 1993-08-16 1994-08-16 B7-2: ctla4/cd28 counter receptor Abandoned AU7526894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10821593A 1993-08-16 1993-08-16
US108215 1993-08-16
PCT/US1994/009252 WO1995005464A1 (en) 1993-08-16 1994-08-16 B7-2: ctla4/cd28 counter receptor

Publications (1)

Publication Number Publication Date
AU7526894A true AU7526894A (en) 1995-03-14

Family

ID=22320925

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75268/94A Abandoned AU7526894A (en) 1993-08-16 1994-08-16 B7-2: ctla4/cd28 counter receptor

Country Status (2)

Country Link
AU (1) AU7526894A (en)
WO (1) WO1995005464A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2071478A1 (en) * 1989-10-27 1991-04-28 Jeffery A. Bluestone Methods and compositions for promoting immunopotentiation
US6406696B1 (en) 1989-10-27 2002-06-18 Tolerance Therapeutics, Inc. Methods of stimulating the immune system with anti-CD3 antibodies
US6824779B1 (en) 1993-07-26 2004-11-30 Dana-Farber Cancer Institute, Inc. Methods for inhibiting the interaction of B7-2 with its natural ligand
US6084067A (en) * 1993-07-26 2000-07-04 Dana-Farber Cancer Institute CTLA4/CD28 ligands and uses therefor
US5811097A (en) * 1995-07-25 1998-09-22 The Regents Of The University Of California Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
US5855887A (en) * 1995-07-25 1999-01-05 The Regents Of The University Of California Blockade of lymphocyte down-regulation associated with CTLA-4 signaling
US6051227A (en) 1995-07-25 2000-04-18 The Regents Of The University Of California, Office Of Technology Transfer Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
US7235653B2 (en) 1996-12-31 2007-06-26 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US6077833A (en) * 1996-12-31 2000-06-20 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US6319906B1 (en) 1996-12-31 2001-11-20 Isis Pharmaceuticals Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
CA2194814A1 (en) 1997-01-10 1998-07-10 Terry L. Delovitch Stimulation of protective t cells to prevent autoimmune disease
US7605238B2 (en) 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
US7030219B2 (en) * 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
US6635750B1 (en) 2000-07-20 2003-10-21 Millennium Pharmaceuticals, Inc. B7-H2 nucleic acids, members of the B7 family
US7432351B1 (en) 2002-10-04 2008-10-07 Mayo Foundation For Medical Education And Research B7-H1 variants
US7960355B2 (en) 2003-05-23 2011-06-14 Isis Pharmaceuticals, Inc. Compositions and methods for the modulation of the expression of B7 protein
US7897582B2 (en) 2003-05-23 2011-03-01 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
AU2005295038B2 (en) 2004-10-06 2012-05-17 Mayo Foundation For Medical Education And Research B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
EP1954311A4 (en) 2005-12-07 2009-12-23 Medarex Inc Ctla-4 antibody dosage escalation regimens
WO2009029342A2 (en) 2007-07-13 2009-03-05 The Johns Hopkins University B7-dc variants
US9302005B2 (en) 2013-03-14 2016-04-05 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
ES2714708T3 (en) 2013-10-01 2019-05-29 Mayo Found Medical Education & Res Procedures for the treatment of cancer in patients with elevated levels of Bim
WO2015179654A1 (en) 2014-05-22 2015-11-26 Mayo Foundation For Medical Education And Research Distinguishing antagonistic and agonistic anti b7-h1 antibodies
EP3171896A4 (en) 2014-07-23 2018-03-21 Mayo Foundation for Medical Education and Research Targeting dna-pkcs and b7-h1 to treat cancer
WO2017075045A2 (en) 2015-10-30 2017-05-04 Mayo Foundation For Medical Education And Research Antibodies to b7-h1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100238712B1 (en) * 1991-06-27 2000-01-15 스티븐 비. 데이비스 Method for regulating the immune response using b7 binding molecules and il4-binding molecules
US5770197A (en) * 1991-06-27 1998-06-23 Bristol-Myers Squibb Company Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules

Also Published As

Publication number Publication date
WO1995005464A1 (en) 1995-02-23

Similar Documents

Publication Publication Date Title
AU7526894A (en) B7-2: ctla4/cd28 counter receptor
AU7364694A (en) Orientation-indifferent battery receptor
AU5367796A (en) Intermodel container including double lap shear joints
AU6227594A (en) Loader system
AU7107794A (en) Cd28 pathway immunosuppression
AU6086294A (en) Incremental linker system
AU4565293A (en) Clutch unit
AU5526094A (en) Improved hot melt adhesives
AU683592B2 (en) Cool-applied hot melt adhesive composition
AU6403194A (en) Non-tactual facilitation support system
AU6679296A (en) Hepadnavirus receptor
AUPN178995A0 (en) Antigen composition
AU5877996A (en) Inverter controlled series compensator
AU6299496A (en) Novel substituted azabicyclic compounds
GB2306614B (en) Hydro/shear in-series powertrain mount
AU7298096A (en) Polyisocyanate composition
AU7638894A (en) B70(b7-2):ctla-4 bonding protein
AU7427494A (en) Collar for cartridge-needle unit
AU3991595A (en) Muscarinic receptor ligands
AU6333194A (en) Drug for neuroprotection
AU1373395A (en) Vpr receptor protein
AU668345B3 (en) Connecting device for form panels
AU4893296A (en) Controlled by-pass reactor
AU5301896A (en) Gentle anti-acne composition
AU6127096A (en) Solar geo-stellar planisphere